[
  {
    "ts": null,
    "headline": "Jim Cramer Calls Incyte “Way Too Cheap”",
    "summary": "Incyte Corporation (NASDAQ:INCY) is one of the relatively cheap S&P 500 stocks Jim Cramer talked about. Cramer mentioned that it is the healthcare stock that “stands out” to him. He stated: “What else? Now, we know healthcare has been mostly a wasteland this year, which is why only four stocks in the group passed the […]",
    "url": "https://finnhub.io/api/news?id=88ec6e55e9e4b8ffd10a6b400f7d5632ad8122e457fa5c470a811ffe647009b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758819938,
      "headline": "Jim Cramer Calls Incyte “Way Too Cheap”",
      "id": 136885800,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Incyte Corporation (NASDAQ:INCY) is one of the relatively cheap S&P 500 stocks Jim Cramer talked about. Cramer mentioned that it is the healthcare stock that “stands out” to him. He stated: “What else? Now, we know healthcare has been mostly a wasteland this year, which is why only four stocks in the group passed the […]",
      "url": "https://finnhub.io/api/news?id=88ec6e55e9e4b8ffd10a6b400f7d5632ad8122e457fa5c470a811ffe647009b4"
    }
  },
  {
    "ts": null,
    "headline": "Keros Therapeutics: A Potential Dart Throw",
    "summary": "Keros Therapeutics: A Potential Dart Throw",
    "url": "https://finnhub.io/api/news?id=05f410b7ecb3b6b6b28725ebf01030ba919cab82defec639b4f33328826534eb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758795349,
      "headline": "Keros Therapeutics: A Potential Dart Throw",
      "id": 136882436,
      "image": "",
      "related": "INCY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=05f410b7ecb3b6b6b28725ebf01030ba919cab82defec639b4f33328826534eb"
    }
  }
]